52w high/low | ₹804.9 / ₹371.75 |
P/E ratio | -115.15 |
Dividend | 0 |
ROE | -13.03 |
ROCE | 0.03 |
Face value | 5 |
Book value | ₹170.17Cr |
Market capital | ₹26,491.92Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Wockhardt Ltd is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world. The company is India's leading research-based global healthcare enterprise with relevance in fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals. The company has twelve manufacturing locations and there are three locations where research and development activities are carried out. Wockhardt has manufacturing and research facilities in India, USA & UK and a manufacturing facility in Ireland. Wockhardt has a significant presence in USA, Europe and India, with 83% of its global revenues coming from international businesses. Wockhardt is the only company in the world where USFDA has given QIDP Status (Qualified lnfectious Diseases Programme) for 5 of our Anti-bacterial discovery programmes - 2 of them are Gram Negative and 3 Gram Positive effective against untreatable 'Superbugs'. Wockhardt's entire anti-infective portfolio particularly addresses the specific bacterial organism where resistances are high and breakthrough antibiotics are needed. Wockhardt Ltd was incorporated on July 8, 1999.